Malcisbo - the sweet vaccines company

Malcisbo develops novel carbohydrate-based vaccines for human & animal health. Based on a novel platform technology, we develop vaccines against bacterial and parasitic diseases.

Our development projects are:

Latest News

  • 25 January 2017

    Malcisbo has been selected as emerging company to present at the Animal Health Investment Forum in London (Feb 2017)

  • 21 December 2016

    Malcisbo participates in a CTI-funded research project on the development of a vaccine against APP.

  • 29 February 2016

    Collaboration with a pharma company

    R&D collaboration with a pharma company targeting our Campylobacter vaccine.